IM Cannabis Corp

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the signing of a binding letter of intent (the "Binding LOI") with cbdMD, Inc. (YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD health & wellness companies. Pursuant to the Binding LOI, the Company will be the exclusive importer of cbdMD, Inc.'s products to Israel.

IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction

Top Marijuana Penny Stocks For Your Watchlist Right Now The post Top Marijuana Penny Stocks To Watch In August? 2 With Potential For Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Marijuana Penny Stocks To Watch In August? 2 With Potential For Next Week

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the voting results from its annual general and special meeting of shareholders held on Wednesday July 28, 2021 (the "Meeting"). A total of 37,108,584 common shares of the Company were voted at the Meeting, representing 65.03% of the Company's issued and outstanding common shares as of the date of the Meeting.

IMC Announces Results of its Annual General and Special Meeting of Shareholders

Aurora Cannabis

Canopy Growth

Clever Leaves Holdings Inc

Grove

GrowGeneration Corp

High Tide

Coffee Holding

Tilray Brands

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

10 Cannabis Stocks That Ran Extra Hot This Week

Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the acquisition of the outstanding ordinary shares of R.A. Yarok Pharm Ltd.

IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way

Could These Top Marijuana Stocks Be Game Changers For Your Portfolio? The post Best Cannabis Stocks For Your Watchlist In Q3 2021? 2 Analysts are Predicting To Have Upside appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Cannabis Stocks For Your Watchlist In Q3 2021? 2 Analysts are Predicting To Have Upside

Multi-country medical and recreational cannabis operator IM Cannabis Corp. (CSE:IMCC) (NASDAQ: IMCC) provided its preliminary second-quarter revenue projections on Friday, as well as a third-quarter outlook and update on its new state-of-the-art logistics center in Germany. The cannabis company projected its net revenue for the quarter to be in the range of $11 million to $12 million, representing a 30% sequential growth.

IM Cannabis Expects Q2 Revenue At $11-12M, Completes State-Of-The-Art Logistics Center In Germany

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces the completion of a new, state-of-the-art logistics centre in Germany (the "Logistics Centre") that will allow Adjupharm GmbH ("Adjupharm"), the Company's fully licensed EU-GMP subsidiary, to internally manage all aspects of its supply chain including, uniquely, the repackaging of bulk cannabis. The Company expects that the Logistics Centre will strongly augment Adjupharm's capabilities as a focal point for IMC's European strategy.

IM Cannabis Provides Update on German Operations and Financial Outlook

IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo German Brand Institute awards IMC with the "German Brand Award 2021" for the Company's successful market launch campaign Israeli Ministerial Committee on Legislative Affairs approves bill for legalization of CBD and decriminalization of cannabis consumers on July 11th TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide a business, legal and regulatory update on its operations in Germany and Israel. Update on Operations in Germany The Company's EU GMP-certified German subsidiary, Adjupharm GmbH ("Adjupharm"), has entered into two new medical cannabis supply agreements that will broaden its product portfolio and provide a greater base from which to distribute medical cannabis across the EU.

IM Cannabis Provides Business, Legal and Regulatory Update

Multi-country medical and recreational cannabis operator, IM Cannabis (CSE: IMCC) (NASDAQ: IMCC) confirmed Friday it has completed its previously announced acquisition of MYM Nutraceuticals (CSE:MYM) valued at CA$85 million ($67.6 million). MYM is a Canadian cultivator, processor and distributor of cannabis through its two wholly-owned subsidiaries – SublimeCulture Inc. and Highland Grow Inc.

Weed Companies On The Move: IM Cannabis Completes Purchase Of MYM Nutraceuticals

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, and MYM Nutraceuticals Inc. ("MYM"), a Canadian cultivator, processor, and distributor of premium cannabis, are pleased to announce, further to IMC's press release on July 6, 2021, the closing of IMC's acquisition of MYM Nutraceuticals Inc. ("MYM") (CSE:MYM), previously announced on April 1, 2021 (the "Transaction"). The Transaction was completed pursuant to a plan of arrangement under the Business Corporations Act (British Columbia).

IM Cannabis Closes Acquisition of MYM Nutraceuticals

Highland Grow is currently profitable on an EBITDA basis, unlocks margin expansion and is expected to be immediately accretive to IM Cannabis Super premium positioning, complementary brands, enhanced distribution and export opportunities provide compelling strategic rationale Closing is expected on or around July 9, 2021 TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 6, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, is pleased to announce that at MYM Nutraceutical Inc.'s ("MYM") (CSE:MYM) special meeting of shareholders held yesterday (the "Meeting"), shareholders of MYM overwhelmingly approved the previously announced transaction pursuant to which IMC will acquire all of the issued and outstanding shares of MYM by way of a court-approved plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement"). The Arrangement was approved by 91.14% of the votes cast by all of the MYM shareholders eligible to vote at the Meeting.

MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis

NEW YORK, July 1, 2021 /PRNewswire/ -- Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the June 29 th & 30th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com. REGISTER OR LOGIN NOW AT:  https://bit.ly/3hlrs95 All presentations will be available for 24/7 on-demand replay for 90 days.

Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

Glass Lewis and Institutional Shareholder Services recommend that MYM shareholders vote FOR Transaction with IMCC Over 90% of committed and tallied common shares are being voted in favor of the Transaction TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 28, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC)(CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, is pleased to announce that Glass, Lewis & Co. ("Glass Lewis") and Institutional Shareholder Services Inc. ("ISS"), two leading independent proxy advisory firms, have each issued positive recommendations of IMC's proposed acquisition of MYM Nutraceuticals Inc. ("MYM") previously announced on April 1, 2021 (the "Transaction"). Both Glass Lewis and ISS recommend that MYM shareholders vote in favor of the resolution to be voted on at the special meeting of shareholders to be held on July 5, 2021.

IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS

NEW YORK, June 22, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications and ATB Capital Markets today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend.

Cannabis Industry Investor Conference: Company Executives Present June 29th & 30th

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released promising results Thursday of a survey that evaluated the effectiveness of seven company-branded medical cannabis strains in treating seven health conditions. What Happened An Israel-based multi-country cannabis operator, IM Cannabis (IMC), enabled this clinical survey that was conducted by an independent contract research organization, Medicanl Ltc.

IM Cannabis Clinical Survey Reports Efficacy Of Its-Branded Stains For Conditions Such As PTSD, Insomnia, Back Pain, IBS

Conditions Evaluated Include Oncology, PTSD, Rheumatoid Arthritis, Chronic Pain, Insomnia, Back Pain and Inflammatory Bowel Diseases Conducted by Leading Contract Research Organization for Cannabis Research, Survey Covered More Than 650 Patients Using FDA-Validated Questionnaires TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 17, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, today unveiled proprietary data from a clinical survey evaluating medicinal cannabis therapy. The patient survey, conducted by Medicanl Ltd.

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

The U.S.-listed shares of IM Cannabis Corp. rallied 3.2% in afternoon trading Thursday, putting them on track for an eighth straight gain, after a bullish call from Alliance Global Partners analyst Aaron Grey, saying the Israel-based cannabis company is an "international play" on legal cannabis. The stock, on track to close at a five-week high, has run up 36.86% during its win streak.

IM Cannabis stock rallies toward an 8-day win streak after bullish analyst call

Israel-based multi-country operator IM Cannabis (CSE:IMCC) (NASDAQ:IMCC) announced it signed a three-year deal with Canadian licensed producer The FLOWR Corporation (OTC:FLWPF), under which the latter will provide its ultra-premium cannabis strains to IM Cannabis for distribution and sale in Israel under the IMC brand.  Oren Shuster, CEO of IM Cannabis said in a statement to Benzinga that, “As the Israeli medical cannabis market continues to expand, demand from patients for premium high-THC products increases.

IM Cannabis, FLOWR Sign Multi-Year Deal To Import Medical Marijuana From Canada To Israel

Trichome JWC Acquisition (TJAC), the Canadian subsidiary of multi-country operator IM Cannabis (CSE:IMCC) (NASDAQ:IMCC), announced last week the launch of WAGNERS, a new adult-use cannabis brand in the premium segment of the market. The announcement also marks the first foray of IM Cannabis, which focuses on the global medical cannabis sector, into the recreational cannabis market.

IM Cannabis Gets Into Adult-Use Cannabis Market With Wagners Brand Launch In Canada

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 7, 2021 / IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce that Focus Medical Herbs Ltd. ("Focus Medical") has signed a multi-year supply agreement with The Flowr Corporation ("Flowr") (TSX.V:FLWR, OTC:FLWPF), a Canadian licensed producer of ultra-premium adult-use recreational and medical cannabis products.

IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand

Launches WAGNERS brand with new cultivars and SKUs MYM shareholder meeting set for July 5, 2021 Substantially completes loan portfolio run-off and realizes a 24% IRR TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / June 1, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide the following update. F irst Closing of the Panaxia Transaction As announced on April 30th, the Company's fully owned Israeli subsidiary, IMC Holdings Ltd.

IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities

Q1 2021 revenues of $8.8 million, an 80% sequential increase from Q4 2020 with Gross margin of 53% Strong sequential growth expected to continue with focus on further expanding premium product portfolio in Israel, contracted shipments into German market and inclusion of full quarter of Canadian sales following successful integration of Trichome TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE /  May 17 , 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce its unaudited financial results for the first quarter ended March 31, 2021. All figures are expressed in Canadian dollars unless otherwise indicated.

IM Cannabis Reports Record Q1 2021 Results

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 10, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE: IMCC), (NASDAQ: IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to announce the closing of its previously announced overnight marketed offering (the "Offering") of 6,086,956 common shares of the Company (each an "Offered Share") at a price of US$5.75 per Offered Share for aggregate gross proceeds of approximately US$35,000,000. The Company also issued 3,043,478 common share purchase warrants (each a "Warrant") to purchasers of Offered Shares, for no additional consideration, that entitle the holders to purchase common shares of the Company at an exercise price of US$7.20 for a term of 5 years from today's date (the "Closing Date").

IM Cannabis Announces Closing of US$ 35 Million Equity Financing

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, announces that is has entered into a best-efforts agency agreement (the "Agency Agreement") in connection with its previously announced overnight marketed offering (the "Offering") of common shares of the Company (each an "Offered Share") and common shares purchase warrants (each a "Warrant"). In connection with the Offering, IMC has also entered into definitive securities purchase agreements with certain institutional investors in the United States on a registered direct basis.

News for IM Cannabis Corp Stock (IMCC)